University of Miami at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
University of Miami takes part in 3 sessions at CTAD 2026 in Boston. Its program spans a phase 3 trial design for neflamapimod in dementia with Lewy bodies and new ways to measure early decline. Its work covers virtual reality measures of everyday function and computerised screening across clinical settings.
| Organization | CTAD 2026 Attendance |
|---|---|
University of Miami Coral Gables, Florida | |
Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from University of Miami
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction